The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran

Dabigatran is an oral direct thrombin inhibitor (DTI) licensed for stroke prevention in atrial fibrillation and likely to be soon approved in Europe for treatment of venous thrombosis. Predictable pharmacokinetics and a reduced risk of intracranial haemorrhage do not negate the potential risk of hae...

Descripción completa

Detalles Bibliográficos
Autores principales: Alikhan, Raza, Rayment, Rachel, Keeling, David, Baglin, Trevor, Benson, Gary, Green, Laura, Marshall, Scott, Patel, Raj, Pavord, Sue, Rose, Peter, Tait, Campbell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913117/
https://www.ncbi.nlm.nih.gov/pubmed/23435652
http://dx.doi.org/10.1136/emermed-2012-201976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913117/
https://www.ncbi.nlm.nih.gov/pubmed/23435652
http://dx.doi.org/10.1136/emermed-2012-201976

Ejemplares similares